Professor Hanne Christensen (@hannekchr) 's Twitter Profile
Professor Hanne Christensen

@hannekchr

Professor (UCPH) and Consultant Neurologist Bispebjerg Hospital Chair of Implementation Committee for Action Plan for Stroke in Europe

ID: 936556977873936385

calendar_today01-12-2017 11:25:58

1,1K Tweet

730 Followers

132 Following

Natalia S. Rost, MD, MPH, FAAN (@nataliarostmd) 's Twitter Profile Photo

Congratulations to a Vascular #Neurologist extraordinaire, Prof. Stephanie Debette, Stéphanie Debette on this terrific culmination of a multi-year research effort to build a program on #VCID & #BrainHealth 🧠🏆 🧬🔬 UNI Bordeaux CHU de Bordeaux Ministère de la Santé et de l'Accès aux soins Inserm 👏👏👏#InnovationSante2030

Congratulations to a Vascular #Neurologist extraordinaire, Prof. Stephanie Debette, <a href="/Debette4/">Stéphanie Debette</a> on this terrific culmination of a multi-year research effort to build a program on #VCID &amp; #BrainHealth 🧠🏆 🧬🔬 <a href="/unibordeaux/">UNI Bordeaux</a> <a href="/CHUBordeaux/">CHU de Bordeaux</a> <a href="/Sante_Gouv/">Ministère de la Santé et de l'Accès aux soins</a> <a href="/Inserm/">Inserm</a> 👏👏👏#InnovationSante2030
European Stroke Org (@esostroke) 's Twitter Profile Photo

The #ELAN #RCT suggests that starting #anticoagulation for atrial fibrillation early after an ischemic #stroke may be as safe and better at preventing further events than delaying. The results of #ELAN are presented now at #ESOC2023 & published today in the NEJM 👇👏

The #ELAN #RCT suggests that starting #anticoagulation for atrial fibrillation early after an ischemic #stroke may be as safe and better at preventing further events than delaying. The results of #ELAN are presented now at #ESOC2023 &amp; published today in the <a href="/NEJM/">NEJM</a> 👇👏
Seemant Chaturvedi (@chaturvedineuro) 's Twitter Profile Photo

ARCADIA shows no benefit with apixaban compared to aspirin in pts with ESUS and atrial cardiopathy. About 4% rate in both groups, no safety concerns. Where does this leave the ESUS concept? #ESOC2023 ⁦Hooman Kamel⁩ ⁦Mitchell Elkind

ARCADIA shows no benefit with apixaban compared to aspirin in pts with ESUS and atrial cardiopathy. About 4% rate in both groups, no safety concerns. Where does this leave the ESUS concept? #ESOC2023
⁦<a href="/hoomankamel/">Hooman Kamel</a>⁩ ⁦<a href="/MitchElkind/">Mitchell Elkind</a>⁩
NeuroNews (@nn_publishing) 's Twitter Profile Photo

Francesca R Pezzella believes there's a "missing link" in the chain of #StrokeCare: the fact #Stroke physicians do not have the time or means to help coordinate actions/policies. Says advocacy + development partners to boost productivity can help here ESOC 2023 @ESOC23 European Stroke Org

Francesca R Pezzella believes there's a "missing link" in the chain of #StrokeCare: the fact #Stroke physicians do not have the time or means to help coordinate actions/policies. Says advocacy + development partners to boost productivity can help here
<a href="/ESOC2023/">ESOC 2023</a> @ESOC23 <a href="/ESOstroke/">European Stroke Org</a>
Else C. Sandset (@ecsandset) 's Twitter Profile Photo

This has been my mantra since the pandemic hit us - we must work to improve stroke also in crisis! Our Ukrainian colleagues (УТІМ/USMS++) are currently my biggest inspiration for this. We must provide stroke care also ik unprecedented times).

Else C. Sandset (@ecsandset) 's Twitter Profile Photo

A great pleasure to be able to present the European Stroke Org Presidential Award to Professor Philip Bath - who I have had the pleasure of working with in the field of BP in acute stroke for 15 years!

Dr Terry Quinn💙 (@drterryquinn) 's Twitter Profile Photo

You know a conference is big when it has its own autobahn signage. #ESOC2023 WAS big (over 4000 stroke-ologists big) but it still felt like a family. Well done European Stroke Org See you all in 2024.

You know a conference is big when it has its own autobahn signage.
#ESOC2023 WAS big (over 4000 stroke-ologists big) but it still felt like a family.
Well done <a href="/ESOstroke/">European Stroke Org</a>
See you all in 2024.
valeria caso (@caso_valeria) 's Twitter Profile Photo

Francesca Romana Pezzella has been elected to the ESO EXcom. She will add an integrative view on implementation of Stroke Care in Europe. Very proud of you.

Francesca Romana Pezzella has been elected to the ESO EXcom. She will add an integrative view on implementation of Stroke Care in Europe. Very proud of you.
European Stroke Org (@esostroke) 's Twitter Profile Photo

#ESOC2023 | Join us in just a few minutes for our closing session where we will present significant #clinicaltrials. Don't miss out on this opportunity before we bid farewell for the year in Munich. #stroke #strokeresearch #strokescience #stroketwitter

#ESOC2023 | Join us in just a few minutes for our closing session where we will present significant #clinicaltrials. Don't miss out on this opportunity before we bid farewell for the year in Munich. 

#stroke #strokeresearch #strokescience #stroketwitter
European Stroke Org (@esostroke) 's Twitter Profile Photo

Unfavourable parenchymal & perfusion imaging criteria, such as low ASPECTS or small penumbras, should not withhold us from giving #EVT to patients with large #ischemic #strokes This IPD meta-analysis of 3 #RCTs shows that #EVT is safe & effective in this population👇 #ESOC2023

Unfavourable parenchymal &amp; perfusion imaging criteria, such as low ASPECTS or small penumbras, should not withhold us from giving #EVT to patients with large #ischemic #strokes
 
This IPD meta-analysis of 3 #RCTs shows that #EVT is safe &amp; effective in this population👇 #ESOC2023
European Stroke Org (@esostroke) 's Twitter Profile Photo

In the #OPTIMALBP #RCT, 305 patients with ischemic #stroke & elevated BP (≥140 mmHg) were randomized to intensive BP lowering vs standard care <24h after #EVT Intensive BP lowering may be harmful – it increases #disability risk without reducing ICH/death risk #ESOC2023 👇

In the #OPTIMALBP #RCT, 305 patients with ischemic #stroke &amp; elevated BP (≥140 mmHg) were randomized to intensive BP lowering vs standard care &lt;24h after #EVT 
 
Intensive BP lowering may be harmful – it increases #disability risk without reducing ICH/death risk
#ESOC2023 👇
Cheryl Carcel (@cheryl_carcel) 's Twitter Profile Photo

What a privilege to be on #ESOC2023 TV yesterday talking about diversity and inclusion in clinical trials with the greats valeria caso and Mike Sharma. Moderated by Joanna Wardlaw and Daniel Strbian. Lots of work to do and hoping we can do it together. Else C. Sandset

What a privilege to be on #ESOC2023 TV yesterday talking about diversity and inclusion in clinical trials with the greats <a href="/caso_valeria/">valeria caso</a> and <a href="/mike_sharma2/">Mike Sharma</a>. Moderated by Joanna Wardlaw and Daniel Strbian. Lots of work to do and hoping we can do it together. <a href="/ECSandset/">Else C. Sandset</a>
Ashkan Shoamanesh (@ash_shoamanesh) 's Twitter Profile Photo

#ESOC2023 Sonolysis re-emerges from the ashes with the SONOBRIDE trial meeting its primary outcome of reducing recurrent stroke in the perioperative phase of carotid revascularization. #neurotwitter Aristeidis Katsanos Demetrios Sahlas

#ESOC2023 Sonolysis re-emerges from the ashes with the SONOBRIDE trial meeting its primary outcome of reducing recurrent stroke in the perioperative phase of carotid revascularization. #neurotwitter <a href="/ArKatsanos/">Aristeidis Katsanos</a> <a href="/DSahlas/">Demetrios Sahlas</a>
Professor Hanne Christensen (@hannekchr) 's Twitter Profile Photo

Sonorthrombolysis is back! Clinically relevant - and statistically significant benefit in the SONOBiRDIE trial. Congratulations to our Czech colleagues 🇨🇿🇨🇿🇨🇿#ESOC2023

Sonorthrombolysis is back! Clinically relevant - and statistically significant  benefit in the SONOBiRDIE trial. Congratulations to our Czech colleagues 🇨🇿🇨🇿🇨🇿#ESOC2023